Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
VOL 2 No. 8 Full Issue - August 2000
1
x
$
20.00
Obsessive-Compulsive Disorder Driven by Aspects of Ritual Addiction: A Case Report and Review of Literature
1
x
$
30.00
Borderline Personality Disorder and Self-Injurious Behaviours— Attention-Seeking or Attachment- Seeking? Psychopharmacological Considerations
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 1, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Escitalopram: A Second-Generation SSRI
1
x
$
0.00
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
1
x
$
30.00
Management of Late-Life Depression: Focus on Comorbid Conditions
1
x
$
30.00
Improved Efficacy of Pregabalin by Restoring Plasma Vitamin D Levels in Migraine: a Case Report
1
x
$
30.00
Christian G. Schmahl, MD: Neurobiological Correlates of Borderline Personality Disorder
1
x
$
30.00
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
1
x
$
30.00
View Cart
Checkout
Home
Store
“Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Intermittent Fluoxetine Dosing in the Treatment of Women With Premenstrual Dysphoria
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
A Discussion on the Methodologies Used to Evaluate Antidepressants
$
15.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Recognition and Treatment of Anxiety Disorders in Primary Care
$
0.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Cause & Effect: Dealing with the Loss of a Spouse
$
0.00
Add to cart
Details
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
$
0.00
Add to cart
Details
Previous
1
…
39
40
41
…
44
Next
Page load link
Go to Top
